Part Description

LP14353-4   Amantadine
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake. Source: National Library of Medicine, MeSH 2006

LOINC Names Get Info

Fully-Specified Name
Amantadine:Titr:Pt:Isolate+Ser:SemiQn:SBT
Long Common Name
Amantadine [Susceptibility] by Serum bactericidal titer
Short Name
Amantadine Titr SBT
Display Name
Amantadine SBT (Isol+S)
Consumer Name Alpha Get Info
Susceptibility to Amantadine

Part Model Get Info

  • Component
    Amantadine
    LP14353-4
    • Analyte
      Amantadine
      LP14353-4
      • Component Numerator
        Amantadine
        LP14353-4
        • Component Numerator Core
          Amantadine
          LP14353-4
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    Titr
    LP6881-9
  • Time
    Pt
    LP6960-1
  • System
    Isolate+Ser
    LP7371-0
    • System Core
      Isolate+Ser
      LP7371-0
    • Super System
      NULL
       
  • Scale
    SemiQn
    LP436123-6
  • Method
    SBT
    LP6501-3

Basic Attributes

Class
ABXBACT
Type
Laboratory
First Released
Version 1.0l
Last Updated
Version 2.75 (MAJ)
Order vs. Observation
Observation

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Amantadin:Arbitrární koncentrace (titr):Časový bod:Izolát a sérum:Semikvantitativní:Sérový titr baktericidních látek
el-GRGreek (Greece)Αμανταδίνη:Titr:Pt:Απομονωμένο στέλεχος+Ορός:Ημιποσοτική:SBT
Synonyms: ABXBACT Pt SBT Titr Αμανταδίνη Απομονωμένο στέλεχος Απομονωμένο στέλεχος+Ορός Ημιποσοτική Ορός
es-ARSpanish (Argentina)amantadina:susceptibilidad:punto en el tiempo:cepa clínica+suero:ordinal:determinación de título bactericida en suero
es-ESSpanish (Spain)Amantadina:Titulo / Factor de dilución:Punto temporal:Aislado y Suero:Semicuantitativo:Títulos séricos bactericidas
Synonyms: Semicuantitativo
es-MXSpanish (Mexico)Amantadina:Título:Punto temporal:Aislado y suero:Cuantitativo:Título bactericida en suero
fr-CAFrench (Canada)Amantadine:Titre:Temps ponctuel:Isolat+Sérum:SemiQn:Pouvoir bactéricide du sérum
fr-FRFrench (France)Amantadine:Titre:Ponctuel:Isolat+Sérum:Semi-Quantitatif:Pouvoir bactéricide du sérum
it-ITItalian (Italy)Amantadina:Titr:Pt:Isolato+Siero:SemiQn:SBT
Synonyms: Isolato & Siero Prova battericida del siero Punto nel tempo (episodio) Siero Suscettibilità agli antibiotici Titolo
ko-KRKorean (Korea, Republic Of)아만타딘:감수성:검사시점:분리주+혈청:순위척도:혈청 살균 역가
nl-NLDutch (Netherlands)amantadine:titer:moment:isolaat en serum:semikwantitatief:serum bacteriocide titer
Synonyms: SBT
pt-BRPortuguese (Brazil)Amantadine:Título:Pt:Isolado/Soro:Qn:Teste bactericida do soro
Synonyms: Symmetrel; Atarin; Influenol; Mantadan; Paramantin; Virofal; Contenton; Dilution factor; Titer; Titre; Ttr; Titered; Point in time; Random; Serum; SR; Islt; Isol; Quantitative; QNT; Quant; Quan; Serum Bactericidal Titer; Serum killing test; ANTIBIOTIC SUSCEPTIBILITIES
zh-CNChinese (China)金刚烷胺:滴定度:时间点:分离株+血清:半定量型:血清杀菌滴度法
Synonyms: SBT SBT 法;血清杀灭试验;Serum killing test;SKT;血清杀灭试验法;血清杀菌滴度;血清杀菌滴度;Serum Bactericidal Titer;SBT;血清杀菌试验;血清杀菌试验法 三环癸胺;金刚胺;阿曼他丁 分离株 & 血清;分离株与血清 分离物;分离菌;分离菌株;隔离种群 基于序列的分型(Sequence based typing,SBT) 基于序列的型别分析 基于序列的型别鉴定 基于序列的类型分析 基于序列的类型鉴定 抗生素敏感性试验;药敏;药敏类;药敏试验;药敏试验类 效价;滴定浓度;滴定率;滴定量;滴度;稀释倍数;稀释因子;稀释系数 时刻;随机;随意;瞬间

Example Units

UnitSource
{titer}Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=16350-1